On September 7th, 2018 Legal Alliance Company team held a corporate workshop “Communication with HCPs and Promotion of Medicines: Rules, Requirements and Limitations Under the Current Legislation of Ukraine”. At the event speakers partner Oleksii Bezhevets and associate Nataliia Abramovych shared practical knowledge and advice with respect to main peculiarities of promotion and advertisement of medicines with workers of an international pharmaceutical company.
During the workshop, the participants also discussed legislative requirements to prevent corruption, in particular restriction in professional activities of HCPs, main requirements to advertisement and dissemination of information on medicines, as well as peculiarities of sponsor and charity support.
At the end of the workshop, the speakers shared their experience regarding marketing activities in the area of law. They also discussed agreements on provision of services / performance of works by HCPs, ways of financing HCPs participation in events, restrictions on personal presents, branded products and other hospitality demonstrations, as well as non-typical promotion methods, including with the use of social network and mobile applications.
Contact the speakers: partner Oleksii Bezhevets bezhevets@l-a.com.ua; associate Nataliia Abramovych abramovych@l-a.com.ua.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
